Dean McMillan1, Simon Gilbody, David Richards. 1. Hull York Medical School and Department of Health Sciences, University of York, United Kingdom. dm645@york.ac.uk
Abstract
BACKGROUND: Although the PHQ-9 is widely used in primary care, little is known about its performance in quantifying improvement. The original validation study of the PHQ-9 defined clinically significant change as a post-treatment score of ≤9 combined with improvement of 50%, but it is unclear how this relates to other theoretically informed methods of defining successful outcome. We compared a range of definitions of clinically significant change (original definition, asymptomatic criterion, reliable and clinically significant change criteria a, b and c) in a clinical trial of a community-level depression intervention. METHOD: Randomised Control Trial of collaborative care for depression. Levels of agreement were calculated between the standard definition, other definitions, and gold-standard diagnostic interview. RESULTS: The standard definition showed good agreement (kappa>0.60) with the other definitions and had moderate, though acceptable, agreement with the diagnostic interview (kappa=0.58). The standard definition corresponded closely to reliable and clinically significant change criterion c, the recommended method of quantifying improvement when clinical and non-clinical distributions overlap. LIMITATIONS: The absence of follow-up data meant that an asymptomatic criterion rather than remission or recovery criteria were used. CONCLUSION: The close agreement between the standard definition and reliable and clinically significant change criterion c provides some support for the standard definition of improvement. However, it may be preferable to use a reliable change index rather than 50% improvement. Remission status, based on the asymptomatic range and a lower PHQ-9 score, may provide a useful additional category of clinical change.
RCT Entities:
BACKGROUND: Although the PHQ-9 is widely used in primary care, little is known about its performance in quantifying improvement. The original validation study of the PHQ-9 defined clinically significant change as a post-treatment score of ≤9 combined with improvement of 50%, but it is unclear how this relates to other theoretically informed methods of defining successful outcome. We compared a range of definitions of clinically significant change (original definition, asymptomatic criterion, reliable and clinically significant change criteria a, b and c) in a clinical trial of a community-level depression intervention. METHOD: Randomised Control Trial of collaborative care for depression. Levels of agreement were calculated between the standard definition, other definitions, and gold-standard diagnostic interview. RESULTS: The standard definition showed good agreement (kappa>0.60) with the other definitions and had moderate, though acceptable, agreement with the diagnostic interview (kappa=0.58). The standard definition corresponded closely to reliable and clinically significant change criterion c, the recommended method of quantifying improvement when clinical and non-clinical distributions overlap. LIMITATIONS: The absence of follow-up data meant that an asymptomatic criterion rather than remission or recovery criteria were used. CONCLUSION: The close agreement between the standard definition and reliable and clinically significant change criterion c provides some support for the standard definition of improvement. However, it may be preferable to use a reliable change index rather than 50% improvement. Remission status, based on the asymptomatic range and a lower PHQ-9 score, may provide a useful additional category of clinical change.
Authors: Jason I Chen; Elizabeth R Hooker; Meike Niederhausen; Heather E Marsh; Somnath Saha; Steven K Dobscha; Alan R Teo Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2019-11-06 Impact factor: 4.328
Authors: Claudia Vesel; Homa Rashidisabet; John Zulueta; Jonathan P Stange; Jennifer Duffecy; Faraz Hussain; Andrea Piscitello; John Bark; Scott A Langenecker; Shannon Young; Erin Mounts; Larsson Omberg; Peter C Nelson; Raeanne C Moore; Dave Koziol; Keith Bourne; Casey C Bennett; Olusola Ajilore; Alexander P Demos; Alex Leow Journal: J Am Med Inform Assoc Date: 2020-07-01 Impact factor: 4.497
Authors: Jon C Mills; Jeffrey S Harman; Robert L Cook; Nicole M Marlow; Christopher A Harle; R Paul Duncan; Bradley N Gaynes; Brian W Pence Journal: AIDS Date: 2017-11-28 Impact factor: 4.177
Authors: Nicholas R Forand; Jeffrey G Barnett; Daniel R Strunk; Mohammed U Hindiyeh; Jason E Feinberg; John R Keefe Journal: Behav Ther Date: 2017-05-01
Authors: Julie L Adams; Maria L G Almond; Edward J Ringo; Wahida H Shangali; Kathleen J Sikkema Journal: Int J Psychiatry Med Date: 2012 Impact factor: 1.210
Authors: Jo Anne Sirey; Patrick J Raue; Nili Solomonov; Clara Scher; Alexandra Chalfin; Paula Zanotti; Jacquelin Berman; George S Alexopoulos Journal: Transl Behav Med Date: 2020-08-07 Impact factor: 3.046
Authors: Sidney H Hankerson; Young A Lee; David K Brawley; Kenneth Braswell; Priya J Wickramaratne; Myrna M Weissman Journal: Am J Prev Med Date: 2015-07-29 Impact factor: 5.043